Streetbeat News

Earnings

PFE

Pfizer's stock is trading higher following the announcement of their Q1 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:46 am

PFE

Pfizer reported Q1 2024 adjusted EPS of $0.82, surpassing the $0.54 estimate, with sales of $14.90B also beating the $14.20B estimate. However, this represents an 18.50% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:46 am

AMD

QQQ

SPY

Wall Street is expected to open lower due to AMD's disappointing earnings, impacting the tech sector and broader market. However, the Federal Reserve's interest rate decision and Chairman Jerome Powell's press conference could influence the market's direction. Analysts see the April market pullback as a correction, setting the stage for a potential summer rally. Premarket trading saw SPDR S&P 500 ETF Trust and Invesco QQQ ETF decline. Economic data and bond yields have pressured stocks, with major indices ending lower in the previous session. Analysts anticipate Powell's guidance on rate outlook and expect a summer rally, considering it's an election year.

Portfolio Pulse from Shanthi Rexaline

May 01, 2024 | 10:44 am

PSN

Parsons has updated its fiscal year 2024 guidance, raising revenue expectations to $6.1B-$6.4B from the previous $5.8B-$6.0B, and adjusted EBITDA to $535M-$575M from $505M-$545M. This adjustment reflects strong Q1 performance and a positive outlook for the year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:41 am

PSN

Parsons Corporation's shares experienced an increase in value after the company reported financial results for the first quarter that surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:39 am

IDXX

IDEXX Laboratories projects its FY24 EPS to be between $10.82 and $11.20, which is below the analyst estimate of $12.69. This forecast suggests a potential downturn in earnings compared to expectations.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:38 am

CVS

CVS has revised its full-year 2024 cash flow from operations guidance downward, from at least $12 billion to at least $10.5 billion. This adjustment reflects changes in the company's financial outlook.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:35 am

PSN

Parsons Corp (NYSE:PSN) reported Q1 2024 adjusted EPS of $0.70, surpassing the $0.62 estimate, and sales of $1.535B, exceeding the $1.377B estimate. This represents a significant increase in earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:35 am

CVS

CVS Health has revised its 2024 adjusted EPS guidance downwards to at least $7.00 from the previous forecast of at least $8.30, against a consensus of $8.27. This adjustment is due to the expectation that the utilization pressure experienced in the Health Care Benefits segment in the first quarter will continue throughout 2024.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:34 am

WLK

Westlake (NYSE:WLK) reported Q1 earnings of $1.34 per share, surpassing the $1.02 estimate by 31.37%, but marking a 56.07% decrease from last year's $3.05. Sales reached $2.98B, exceeding the $2.93B forecast by 1.54%, yet down 11.35% from the previous year's $3.36B.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:34 am